Bio-Rad Laboratories (BIO) total debt

Total debt · fiscal 2025
$1.39B

Bio-Rad Laboratories (BIO) carried total debt of $1.39B at the end of fiscal 2025 (December 31, 2025). That is 0.8% higher than the $1.37B of fiscal 2024. Figures as of 18 Nov 2026, 09:49 UTC, from the company's filings with the SEC and Yahoo Finance.

Key facts

Total debt, fiscal 2025
$1.39B
Change on fiscal 2024
+0.8%
Highest on record
$1.41Bfiscal 2023
Lowest on record
$435.82Mfiscal 2013
Fiscal years on record
82010–2025

Figures as of . Older fiscal years come from the company's filings with the SEC, recent ones from Yahoo Finance. Amounts are in USD. Figures, not advice.

Bio-Rad Laboratories total debt, in more detail

Across the 8 fiscal years on record (2010–2025), the highest was $1.41B in fiscal 2023 and the lowest $435.82M in fiscal 2013.

Total debt was 0.2× shareholders' equity at the end of fiscal 2025.

History · 8 fiscal years

Total debt by fiscal year

Bio-Rad Laboratories total debt, year by year

Bio-Rad Laboratories (BIO) total debt by fiscal year
Fiscal yearTotal debtChangeYear endedDebt ÷ equity
2025$1.39B 0.8% up0.2×
2024$1.37B 2.2% down0.2×
2023$1.41B 1.3% up0.2×
2022$1.39B—0.1×
2013$435.82M 40.5% down0.2×
2012$732.61M 0.0% up0.4×
2011$732.30M 24.1% down0.4×
2010$964.20M—0.6×

Change is on the fiscal year before; a dash means that year is not on record or the earlier figure was not positive. A dash anywhere else means the figure was not reported or cannot be computed — it is never filled in.

Method

How it is calculated

Total debt adds the short-term and long-term borrowings on the balance sheet at the fiscal year-end; debt-to-equity divides it by shareholders' equity and is left blank when equity is negative.

How to read it

Debt magnifies results in both directions — set it against cash, equity and the profit available to pay the interest rather than reading it alone.

Total debt at health care companies of similar size

Total debt of Bio-Rad Laboratories and comparable companies
CompanyTotal debtFiscal year
Ensign Group ENSG$2.21B2025
Vaxcyte PCVX$117.48M2025
Bio-Rad Laboratories BIO$1.39B2025
Molina Healthcare MOH$3.95B2025
Spyre Therapeutics SYRE$4.63M2022
Qiagen QGEN$1.81B2025

The latest fiscal year on record for each company, in the currency it reports in. Fiscal years end at different times of year.

More on BIO

Bio-Rad Laboratories, figure by figure

Bio-Rad Laboratories (BIO) overview: price, valuation and scorecardAll health care companies by market value

Bio-Rad Laboratories total debt: questions and answers

How much debt does Bio-Rad Laboratories have?

Bio-Rad Laboratories (BIO) carried total debt of $1.39B at the end of fiscal 2025 (December 31, 2025). That is 0.8% higher than the $1.37B of fiscal 2024.

What are the highest and lowest total debt figures on record for Bio-Rad Laboratories?

Across the 8 fiscal years on record (2010–2025), the highest was $1.41B in fiscal 2023 and the lowest $435.82M in fiscal 2013.

How does Bio-Rad Laboratories's debt compare with its equity?

Total debt was 0.2× shareholders' equity at the end of fiscal 2025.

How is Bio-Rad Laboratories's total debt calculated?

Total debt adds the short-term and long-term borrowings on the balance sheet at the fiscal year-end; debt-to-equity divides it by shareholders' equity and is left blank when equity is negative. For Bio-Rad Laboratories it is on record here for 8 fiscal years, 2010 to 2025.

Fiscal years are named for the calendar year they end in.

Cite this page

Funkfolio, “Bio-Rad Laboratories (BIO) total debt”, data as of 18 November 2026. https://funkfolio.com/stock/BIO/total-debt

Underlying data: the company's filings with the SEC and Yahoo Finance.